GeoVax Labs Inc (GOVX) FinancialsGOVXFinancialGeoVax Labs Inc

Evaluating the bottom line, GeoVax Labs Inc maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at N/A, while the net margin is N/A. These profitability ratios, combined with a Return on Equity (ROE) of -891.59%, provide a clear picture of how effectively GOVX converts its operational activities into shareholder value.

In the context of the broader market, GOVX competes directly with industry leaders such as LABT and CVKD. With a market capitalization of $5.28M, it holds a significant position in the sector. When comparing efficiency, GOVX's gross margin of N/A stands against LABT's N/A and CVKD's N/A. Such benchmarking helps identify whether GeoVax Labs Inc is trading at a premium or discount relative to its financial performance.

GeoVax reported a gross margin of 100% in recent quarters, indicating strong revenue potential from its vaccine programs, although it has faced significant net losses, with a net income of -4426578 USD in Q2 2026.